$MGNX 14% Afterhours Breakout on positive phase 3 results
Afterhours Macrogenics Inc has announced Positive Results from Phase 3 SOPHIA Study of Margetuximab in Patients with HER2-Positive Metastatic Breast Cancer. This has resulted in a 15% jump in price on high volume , we will looking for continuation tomorrow, this could be a flyer.
Official InvestorsHub (IHUB) Profile for TopMarketGainers.com. Since 2009, we are the #1 Source For #FREE Winning #NASDAQ & #NYSE-Listed Alerts!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.